News | 14 January 2013
Biotest Pharmaceuticals (BPC), a wholly owned US subsidiary of Biotest, and ADMA Biologics have signed a strategic long-term manufacturing, supply and licensing deal. According to the deal, BPC will provide manufacturing services and license ...
Click on the link to read the full article at Pharmaceutical Business Review
(This link will open in a new window)